No Data
No Data
We're Hopeful That Rocket Pharmaceuticals (NASDAQ:RCKT) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares sinc
KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2024-INV1 (RCKT 2024-INV1)
NEW YORK--(BUSINESS WIRE)--#creditratingagency--KBRA assigns preliminary ratings to 48 classes of mortgage pass-through certificates from RCKT Mortgage Trust 2024-INV1 (RCKT 2024-INV1). The transactio
(SEC Amendment) Rocket Pharmaceuticals(RCKT.US) Director Sells US$7.79 Million in Common Stock
$Rocket Pharmaceuticals(RCKT.US)$ Director Makker Gotham sold 274K shares of common stock on Mar 21, 2024 at an average price of $28.4341 for a total value of $7.79 million.Source: Announcement What i
Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?
Rocket Pharmaceuticals: Poised for Growth With Upcoming Commercial Transition and Undervalued Assets
Rocket Pharmaceuticals (NASDAQ:RCKT) Is In A Good Position To Deliver On Growth Plans
No Data